Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check7 days agoChange DetectedThe Record History adds the latest revision v3.5.4, replacing v3.5.3. This reflects a small metadata update to the page's revision log rather than substantive changes to the study record.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history, and the previous v3.5.2 entry has been removed. This updates the page’s release notes in the history log.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry (v3.5.2) was added to the history. The previous revision entry (v3.5.0) was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history now includes Revision v3.5.0 and omits Revision v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record history now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded Revision: v3.4.2 to the study history. Removed the government funding lapse notice and deleted Revision: v3.4.1.SummaryDifference0.8%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.